ETHYL 1-(2-MORPHOLINOETHYL)-1H-PYRAZOLE-4-CARBOXYLATE, 95.0%, 250mg

3,3'-DIMETHYLAZOBENZENE, 98%, 5g

2-Bromo-1-(3-chlorophenyl)propan-1-one, 95.0%, 1g

2-Chloro-2-propen-1-ol, 98%, 1g

Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 25g

N,N-Diethylaniline , >=98.5%, for synthesis, 250 ml, glass packaging

2-(Piperazin-1-yl)ethanamine, 95.0%, 500ml

4-Cyclohexylbenzenesulfonyl chloride, 97.0%, 1g

METHYL 4-BROMO-3-METHYLPICOLINATE, 95.0%, 100mg

3-Chloro-4-fluoroanisole, 97.0%, 10g

(2,6-Dimethylphenyl)(1H-imidazol-4-yl)methanol, 95.0%, 100mg

Benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95%, 250mg

2-Cyclopentyl-2-oxoacetic acid, 97%, 1g